Investigating the PGC1alpha pathway and its role in energy metabolism
PGC1alpha Pathway: Novel Intracellular and Extracellular Mediators
This study is looking at how a specific protein called RBM43 affects energy use in fat cells and how problems with this process might lead to obesity and diabetes, with the hope of finding new ways to help people with these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10881930 on NIH RePORTER |
What this research studies
This research focuses on the PGC1alpha pathway, which is crucial for regulating mitochondrial function and energy metabolism in various tissues. It aims to understand how deficiencies in this pathway contribute to conditions like obesity and diabetes. The study will explore the role of a specific RNA-binding factor, RBM43, in controlling the translation of PGC1alpha, using genetic and biological approaches. By examining how RBM43 affects energy metabolism in adipose tissues, the research seeks to uncover potential therapeutic targets for metabolic disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with obesity, diabetes, or related metabolic conditions.
Not a fit: Patients without metabolic disorders or those not affected by obesity or diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for obesity, diabetes, and related metabolic disorders.
How similar studies have performed: Previous research has shown promising results in understanding the PGC1alpha pathway, indicating that this approach has potential for significant advancements.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Spiegelman, Bruce M. — Dana-Farber Cancer Inst
- Study coordinator: Spiegelman, Bruce M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.